124 related articles for article (PubMed ID: 10644688)
1. Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase.
Noguchi S; Jianmongkol S; Bender AT; Kamada Y; Demady DR; Osawa Y
J Biol Chem; 2000 Jan; 275(4):2376-80. PubMed ID: 10644688
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydrobiopterin protects against guanabenz-mediated inhibition of neuronal nitric-oxide synthase in vitro and in vivo.
Dunbar AY; Jenkins GJ; Jianmongkol S; Nakatsuka M; Lowe ER; Lau M; Osawa Y
Drug Metab Dispos; 2006 Sep; 34(9):1448-56. PubMed ID: 16738031
[TBL] [Abstract][Full Text] [Related]
3. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
4. Metabolism-based inactivation of neuronal nitric-oxide synthase by components of cigarette and cigarette smoke.
Demady DR; Lowe ER; Everett AC; Billecke SS; Kamada Y; Dunbar AY; Osawa Y
Drug Metab Dispos; 2003 Jul; 31(7):932-7. PubMed ID: 12814971
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the heme prosthetic group of neuronal nitric-oxide synthase during inactivation by N(G)-amino-L-arginine in vitro and in vivo.
Vuletich JL; Lowe ER; Jianmongkol S; Kamada Y; Kent UM; Bender AT; Demady DR; Hollenberg PF; Osawa Y
Mol Pharmacol; 2002 Jul; 62(1):110-8. PubMed ID: 12065761
[TBL] [Abstract][Full Text] [Related]
6. Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz.
Nakatsuka M; Nakatsuka K; Osawa Y
Drug Metab Dispos; 1998 May; 26(5):497-501. PubMed ID: 9571232
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination and degradation of neuronal nitric-oxide synthase in vitro: dimer stabilization protects the enzyme from proteolysis.
Dunbar AY; Kamada Y; Jenkins GJ; Lowe ER; Billecke SS; Osawa Y
Mol Pharmacol; 2004 Oct; 66(4):964-9. PubMed ID: 15235101
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibition of ERK1/2 activity in cells expressing neuronal nitric-oxide synthase.
Raines KW; Cao GL; Porsuphatana S; Tsai P; Rosen GM; Shapiro P
J Biol Chem; 2004 Feb; 279(6):3933-40. PubMed ID: 14602725
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitylation of neuronal nitric-oxide synthase by CHIP, a chaperone-dependent E3 ligase.
Peng HM; Morishima Y; Jenkins GJ; Dunbar AY; Lau M; Patterson C; Pratt WB; Osawa Y
J Biol Chem; 2004 Dec; 279(51):52970-7. PubMed ID: 15466472
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of neuronal nitric-oxide synthase in vitro and in vivo.
Bender AT; Demady DR; Osawa Y
J Biol Chem; 2000 Jun; 275(23):17407-11. PubMed ID: 10751385
[TBL] [Abstract][Full Text] [Related]
11. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
[TBL] [Abstract][Full Text] [Related]
12. Changes in the dimeric state of neuronal nitric oxide synthase affect the kinetics of secretagogue-induced insulin response.
Lajoix AD; Pugnière M; Roquet F; Mani JC; Dietz S; Linck N; Faurie F; Ribes G; Petit P; Gross R
Diabetes; 2004 Jun; 53(6):1467-74. PubMed ID: 15161750
[TBL] [Abstract][Full Text] [Related]
13. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
Babu BR; Griffith OW
J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
[TBL] [Abstract][Full Text] [Related]
14. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
15. Neuronal nitric oxide synthase catalyzes the reduction of 7-ethoxyresorufin.
Jiang HB; Ichikawa Y
Life Sci; 1999; 65(12):1257-64. PubMed ID: 10503941
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
19. N omega-propargyl-L-arginine and N omega-hydroxy-N omega-propargyl-L-arginine are inhibitors, but not inactivators, of neuronal and macrophage nitric oxide synthases.
Fast W; Levsky ME; Marletta MA; Silverman RB
Bioorg Med Chem; 1997 Aug; 5(8):1601-8. PubMed ID: 9313865
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway.
Musial A; Eissa NT
J Biol Chem; 2001 Jun; 276(26):24268-73. PubMed ID: 11312270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
